Skip to main content
    L

    Lantheus Holdings Inc (LNTH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $99.99
    -0.01 (-0.01%)

    Market Cap: $6.53B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +60.48%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.35
    Range$1.30 - $1.44
    5 analysts
    EPS RevisionsNo revisions (7d)
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$1.30+4.4%
    60d ago$1.30+4.4%
    30d ago$1.28+5.6%
    7d ago$1.350.0%
    Current$1.35
    Revenue Consensus
    $362M
    Range$354M - $368M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.71
    Range$1.56 - $1.80
    3 analysts
    Revenue Consensus
    $420M
    Range$402M - $439M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.71---
    Sep 26EST
    		-$1.35---
    Jun 26
    Reported Aug 6
    		$1.32$1.11+18.92%Beat-15.9%
    Mar 26
    Reported May 7
    		$1.46$1.23+18.70%Beat-4.6%
    Dec 25
    Reported Feb 26
    		$1.46$0.94+55.32%Beat-8.2%
    Sep 25
    Reported Nov 6
    		$1.27$1.27+0.00%Beat-25.3%
    Jun 25
    Reported Aug 6
    		$1.57$1.68-6.55%Miss-12.8%
    Mar 25
    Reported May 7
    		$1.53$1.65-7.27%Miss-9.5%
    Dec 24
    Reported Feb 26
    		$1.59$1.54+3.04%Beat-9.1%
    Sep 24
    Reported Nov 6
    		$1.70$1.56+8.97%Beat+15.6%
    Jun 24
    Reported Jul 31
    		$1.80$1.83-1.64%Miss+16.9%
    Mar 24
    Reported May 2
    		$1.69$1.54+9.74%Beat+15.0%
    Dec 23
    Reported Feb 22
    		$1.75$1.45+20.69%Beat+27.7%
    Sep 23
    Reported Nov 2
    		$1.47$1.32+11.36%Beat+48.5%
    Jun 23
    Reported Aug 3
    		$1.54$1.31+17.56%Beat+73.0%
    Mar 23
    Reported May 4
    		$1.47$1.29+13.95%Beat+51.5%
    Dec 22
    Reported Feb 23
    		$1.37$0.96+42.71%Beat+448.0%
    Sep 22
    Reported Nov 3
    		$0.99$0.83+19.28%Beat+1137.5%
    Jun 22
    Reported Aug 4
    		$0.89$0.70+27.14%Beat+709.1%
    Mar 22
    Reported Apr 29
    		$0.97$0.46+110.87%Beat+1840.0%
    Dec 21
    Reported Feb 24
    		$0.25$0.17+47.06%Beat+257.1%
    Sep 21
    Reported Nov 4
    		$0.08$0.06+33.33%Beat+100.0%
    Jun 21
    Reported Jul 28
    		$0.11$0.05+120.00%Beat+10.0%
    Mar 21
    Reported May 4
    		$0.05$-0.01+600.00%Beat-86.1%
    Dec 20
    Reported Feb 25
    		$0.07$0.01+600.00%Beat-79.4%
    Sep 20
    Reported Nov 5
    		$0.04$-0.06+166.67%Beat-85.7%
    Jun 20
    Reported Jul 30
    		$0.10$0.06+66.67%Beat-63.0%
    Mar 20
    Reported Apr 30
    		$0.36$0.29+24.14%Beat+28.6%
    Dec 19
    Reported Feb 25
    		$0.34$0.30+13.33%Beat+41.7%
    Sep 19
    Reported Oct 31
    		$0.28$0.21+33.33%Beat+16.7%
    Jun 19
    Reported Jul 25
    		$0.27$0.25+8.00%Beat+3.8%
    Mar 19
    Reported Apr 30
    		$0.28$0.25+12.00%Beat+27.3%
    Dec 18
    Reported Feb 19
    		$0.24$0.14+71.43%Beat+100.0%
    Sep 18
    Reported Oct 30
    		$0.24$0.18+33.33%Beat+0.0%
    Jun 18
    Reported Aug 1
    		$0.26$0.22+18.18%Beat-38.1%
    Mar 18
    Reported May 2
    		$0.22$0.22+0.00%Beat-21.4%
    Dec 17
    Reported Feb 26
    		$0.12$0.20-40.00%Miss-33.3%
    Sep 17
    Reported Nov 2
    		$0.24$0.20+20.00%Beat-
    Jun 17
    Reported Aug 1
    		$0.42$0.23+82.61%Beat-
    Mar 17
    Reported May 2
    		$0.28$0.19+47.37%Beat-
    Dec 16
    Reported Feb 21
    		$0.18$0.13+38.46%Beat-

    Key Metrics

    Valuation
    P/E Ratio18.15EV/EBITDA14.28x
    Price/FCF17.41xFCF Yield5.74%
    Profitability
    Profit Margin17.70%Operating Margin25.80%
    ROE22.20%ROIC15.42%
    Financial Health
    Debt/Equity0.44xInterest Coverage19.33x
    Current Ratio3.06xQuick Ratio2.89x
    Trading Statistics
    Beta-0.06Avg Volume945.15K
    52-Week High$111.8652-Week Low$50.16

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$100.07
    SMA 20$99.97
    SMA 50$100.40
    SMA 200$89.59
    EMA 10$100.02
    EMA 20$100.09
    EMA 50$100.39
    EMA 200$92.19

    MACD

    Line: -0.15Signal: -0.22Hist: 0.06

    ADX

    ADX: 13.6+DI: 13.1-DI: 17.0

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down56.0
    PSAR$100.97

    Bollinger Bands

    Upper Band$100.49
    Lower Band$99.45
    %B Position104%(Upper)
    Band Width0.52

    RSI (14-Day)

    Neutral
    45.6

    Momentum Oscillators

    Stoch %K63.6
    Stoch %D67.6
    Williams %R-37.6
    ROC (10d)0.3%
    Momentum0.34
    CCI (20d)5.0
    MFI (14d)26.3

    Volatility Measures

    ATR (14d)$0.45(0.4%)
    StdDev (20d)0.26
    Hist Vol2.8%(Low)

    Volume Flow

    VWAP$100.04
    OBV-9.1M
    AD Line14.6M
    CMF (20d)-0.463

    Volume Metrics

    Avg Vol (20d)971.7K
    Vol Ratio0.9x
    VWMA (20d)$99.94

    Pivot Points

    R3$100.50
    R2$100.36
    R1$100.18
    Pivot Point$100.05
    S1$99.87
    S2$99.73
    S3$99.55

    Advanced Oscillators

    TSI-9.53
    Ultimate Osc30.6
    KST-4.91

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$388.18M$377.33M$406.79M$384.01M$378.05M$372.76M$391.11M$378.73M$394.09M$369.98M$354.00M$319.95M
    Cost of Revenue$146.32M$146.41M$165.91M$161.65M$137.03M$135.06M$142.56M$136.61M$138.32M$118.20M$124.13M$120.00M
    Gross Profit$241.85M$230.92M$240.88M$222.37M$241.01M$237.70M$248.54M$242.13M$255.77M$251.78M$229.87M$199.95M
    Operating Expenses$141.64M$149.60M$163.69M$178.75M$153.04M$135.63M$134.67M$108.38M$153.04M$151.40M$92.38M$87.59M
    R&D$38.20M$39.38M$47.48M$48.02M$45.49M$36.31M$35.33M$24.15M$60.60M$48.02M$16.82M$14.45M
    SG&A$20.63M$57.53M$69.89M$81.90M$66.52M$56.82M$57.87M$40.52M$47.41M$47.90M$40.30M$35.74M
    Operating Income$100.22M$81.33M$77.18M$43.62M$87.97M$102.07M$113.87M$133.74M$102.73M$100.38M$137.49M$112.36M
    Interest Income$6.26M$4.97M$3.07M$3.62M$7.21M$9.48M$9.56M$9.80M$8.92M$8.55M$7.55M$4.54M
    Interest Expense$4.92M$4.86M$5.08M$4.95M$4.92M$4.80M$5.04M$4.90M$4.86M$4.86M$5.04M$5.05M
    Income Before Tax$93.83M$156.41M$70.36M$42.38M$104.52M$96.53M$-783,000$176.12M$84.37M$171.27M$138.40M$159.96M
    Income Tax Expense$18.80M$37.99M$16.28M$14.61M$25.76M$23.58M$11.01M$45.02M$22.30M$40.20M$35.02M$28.00M
    Net Income$75.03M$118.42M$54.09M$27.77M$78.75M$72.94M$-11,790,000$131.09M$62.07M$131.07M$103.38M$131.96M
    EBITDA$121.32M$183.95M$98.26M$67.74M$122.67M$114.96M$21.55M$198.10M$104.06M$191.57M$158.46M$179.66M
    EBIT$98.74M$161.27M$75.44M$47.33M$109.43M$101.33M$4.26M$181.02M$89.24M$176.13M$143.44M$165.01M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LNTH

    Government Contracts

    Gov Obligations (TTM)
    $41.10M
    Gov Obligations / Revenue
    2.7%
    Obligations YoY
    39.5%
    Active Awards
    84
    New Awards (TTM)
    39
    Avg Remaining Term
    4.9 mo

    Top agency: Department of Veterans Affairs at 96.1% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25026N0354Department of Veterans AffairsDepartment of Veterans Affairs$2.36MMar 1, 2026
    36C25026N0359Department of Veterans AffairsDepartment of Veterans Affairs$1.97MMar 1, 2026
    36C25726N0177Department of Veterans AffairsDepartment of Veterans Affairs$1.81MJan 6, 2026
    36C24526N0180Department of Veterans AffairsDepartment of Veterans Affairs$1.81MJan 2, 2026
    36C26126N0023Department of Veterans AffairsDepartment of Veterans Affairs$1.73MOct 1, 2025
    36C26226F0031Department of Veterans AffairsDepartment of Veterans Affairs$1.57MNov 4, 2025
    36C24626N0284Department of Veterans AffairsDepartment of Veterans Affairs$1.50MJan 1, 2025
    36C24826N0189Department of Veterans AffairsDepartment of Veterans Affairs$1.25MJan 1, 2026
    36C24625N1142Department of Veterans AffairsDepartment of Veterans Affairs$1.21MSep 1, 2025
    36C24826N0071Department of Veterans AffairsDepartment of Veterans Affairs$1.20MOct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Lantheus Holdings (LNTH) Could Be 7% Undervalued As Its Pipeline Story Builds

    Lantheus Holdings (LNTH) is considered modestly undervalued, with a fair value estimated at $107.74 against its current price of $99.99...

    Simply Wall Street•10/16/26•Somewhat-Bullish

    Banks Vie to Back $4.25B Debt for Curium-Lantheus

    Lenders are competing for roles in a $4.25 billion financing package to support Curium's acquisition of Lantheus Holdings Inc., with JPMorgan leading the effort. The debt includes a large term loan...

    Briefs Finance•10/15/26•Somewhat-Bullish

    LNTH Downgraded by Mizuho -- Price Target Lowered to $109

    Mizuho downgraded Lantheus Holdings (LNTH) to a Neutral rating, lowering its price target from $115.00 to $109.00, reflecting cautious sentiment from analysts. While LNTH has a strong GF Score™ of 82/100...

    GuruFocus•10/13/26•Bearish

    Technical Reactions to LNTH Trends in Macro Strategies

    This article provides a technical analysis of Lantheus Holdings Inc. (NASDAQ: LNTH) by the Quantitative Research Desk. It indicates a neutral near and mid-term outlook but a positive long-term bias...

    Stock Traders Daily•10/12/26•Neutral

    Lantheus Holdings, Inc. (LNTH) Stock Forecasts

    Argus has raised its target price for Lantheus Holdings Inc. (LNTH) to $105.00, with the company's current stock price at $100.33. Lantheus Holdings develops diagnostic products for the U.S. healthcare sector....

    Yahoo! Finance Canada•10/9/26•Bullish

    LNTH Valuation and Fair Value

    P/E
    18.1x
    Forward P/E
    14.3x
    EV/EBITDA
    14.3x
    P/FCF
    17.4x
    PEG
    0.6x
    P/B
    5.1x
    See GNG's fair value

    LNTH Profitability: Margins, ROIC and FCF

    Gross margin
    60.1%
    Operating margin
    25.8%
    Net margin
    17.7%
    ROIC
    15.4%
    ROE
    22.2%
    FCF margin
    24.9%
    FCF yield
    5.7%

    LNTH Competitors

    CompanyTicker
    Amneal Pharmaceuticals, Inc. Class A Common StockAMRX
    Iovance Biotherapeutics IncIOVA
    Praxis Precision Medicines IncPRAX
    GRAIL, LLCGRAL
    Merus BVMRUS
    Centessa Pharmaceuticals PLC ADRCNTA
    PACS Group, Inc.PACS
    Kiniksa Pharmaceuticals LtdKNSA

    Sector: Healthcare

    LNTH Analyst Ratings

    Consensus
    Hold
    Analysts
    10
    Strong Buy
    1
    Buy
    2
    Hold
    7
    Sell
    0
    Strong Sell
    0

    LNTH Bull Case vs Bear Case

    Bull case

    • LNTH earns a 15.4% return on invested capital.
    • LNTH converts 24.9% of revenue into free cash flow.

    LNTH Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    11.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.35
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 1 down

    Frequently Asked Questions About LNTH

    Does LNTH pay dividends?

    Lantheus Holdings Inc (LNTH) does not currently pay a regular dividend.

    What is LNTH's P/E ratio?

    Lantheus Holdings Inc has a price-to-earnings (P/E) ratio of 18.15.

    What is LNTH's market cap?

    Lantheus Holdings Inc (LNTH) has a market capitalization of $6.53B with a current stock price of $99.99.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In